Results 121 to 130 of about 3,662,867 (341)

South African Propolis: Anti‐Helicobacter pylori Activity, Chemistry, and Toxicity

Chemistry &Biodiversity, EarlyView.
ABSTRACT Propolis, a resin‐like substance produced by bees, has previously shown antimicrobial activity against the ulcer‐causing gut pathogen Helicobacter pylori. South African propolis, however, was yet to be investigated. This study aimed to investigate a comprehensive range of South African propolis for its antimicrobial activity against H.
Sarhana Dinat, Ané Orchard, Efficient Ncube, Weiyang Chen, Alvaro Viljoen, Sandy van Vuuren   +5 more
wiley   +1 more source

Lower comorbidity scores and severity levels in Veterans Health Administration hospitals: a cross-sectional study

BMC Health Services Research
Background Previous studies found that documentation of comorbidities differed when Veterans received care within versus outside Veterans Health Administration (VHA).
Matthew P. Dizon, Adam Chow, Michael K. Ong, Ciaran S. Phibbs, Megan E. Vanneman, Yue Zhang, Jean Yoon   +6 more
doaj   +1 more source

Chemical Composition and In Vitro Antibiofilm Action of Varronia curassavica Jacq. (Boraginaceae) Essential Oil: A Promising Natural Agent Against Bacterial Infections

Chemistry &Biodiversity, EarlyView.
ABSTRACT Antimicrobial resistance is an increasing threat to public health, with alarming estimates of mortality rates. In this context, the clinical properties of Varronia curassavica Jacq. are highlighted due to its biological and pharmacological activities.
José Thyálisson da Costa Silva, Gabriel Gonçalves Alencar, Nara Juliana Santos Araújo, Lariza Leisla Leandro Nascimento, Saulo Almeida Menezes, Dhenes Ferreira Antunes, Adrielle Rodrigues Costa, Murilo Felipe Felício, Cicero dos Santos Leandro, Luis Pereira de Morais, Marcos Aurélio Figueirêdo dos Santos, Severino Denicio Gonçalves de Sousa, Julimery Gonçalves Ferreira Macedo, João Pereira da Silva Junior, Ana Carolina Ferreira Araujo, Maísa Freire Cartaxo Pires de Sá, Jacqueline Cosmo Andrade‐Pinheiro, Henrique Douglas Melo Coutinho, José Weverton Almeida‐Bezerra   +18 more
wiley   +1 more source

Evidence of Glycolysis Up-Regulation and Pyruvate Mitochondrial Oxidation Mismatch During Mechanical Unloading of the Failing Human Heart

JACC: Basic to Translational Science, 2016
This study sought to investigate the effects of mechanical unloading on myocardial energetics and the metabolic perturbation of heart failure (HF) in an effort to identify potential new therapeutic targets that could enhance the unloading-induced cardiac
Nikolaos A. Diakos, MD, PhD, Sutip Navankasattusas, PhD, E. Dale Abel, MD, PhD, Jared Rutter, PhD, Lauren McCreath, BS, Peter Ferrin, BS, Stephen H. McKellar, MD, Dylan V. Miller, MD, Song Y. Park, PhD, Russell S. Richardson, PhD, Ralph Deberardinis, MD, James E. Cox, PhD, Abdallah G. Kfoury, MD, Craig H. Selzman, MD, Josef Stehlik, MD, James C. Fang, MD, Dean Y. Li, MD, PhD, Stavros G. Drakos, MD, PhD   +17 more
doaj   +1 more source

The Veterans Health Administration: Taking Home Telehealth Services to Scale Nationally [PDF]

, 2013
Since the 1990s, the Veterans Health Administration (VHA) has used information and communications technologies to provide high-quality, coordinated, and comprehensive primary and specialist care services to its veteran population.
Andrew Broderick
core  

Impact of Diabetes on Long‐Term Outcomes of Percutaneous Coronary Intervention for Coronary Bifurcation Lesions

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Diabetes mellitus (DM) is a well‐known risk factor for cardiovascular diseases, including coronary artery diseases (CAD). Complex percutaneous coronary intervention (PCI) such as PCI for bifurcation lesions often yields poor outcomes, especially in DM patients.
Subin Lim, Soon Jun Hong, Ju Hyeon Kim, Jung‐Joon Cha, Hyung Joon Joo, Jae Hyoung Park, Cheol Woong Yu, Do‐Sun Lim, Chang‐Wook Nam, the COBIS III investigators, Hyo‐Soo Kim, Woo Jung Chun, Seung‐Ho Hur, Seung Hwan Han, Seung‐Woon Rha, In‐Ho Chae, Jin‐Ok Jeong, Jung Ho Heo, Junghan Yoon, Ki Hong Choi, Young Bin Song, Hyeon‐Cheol Gwon, Jong‐Seon Park, Myeong‐Ki Hong, Joon‐Hyung Doh, Kwang Soo Cha, Doo‐Il Kim, Sang Yeub Lee, Kiyuk Chang, So‐Yeon Choi, Myung Ho Jeong, Bon‐Kwon Koo   +31 more
wiley   +1 more source

Treatment With Phosphodiesterase 5 Inhibitors and Long‐Term Outcomes in Patients Undergoing Coronary Angiography and Cardiac Catheterization

Catheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The effects of phosphodiesterase 5 (PDE5) inhibitors on the incidence of long‐term outcomes in patients with cardiovascular disease are not well understood. Objective: We studied the association between PDE5 inhibitor therapy and the incidence of adverse cardiovascular major adverse cardiovascular events (MACE) in patients ...
Sumon Roy, Annette Min, Edward O. McFalls, Robert A. Perera, Fadi N. Salloum, Ion S. Jovin   +5 more
wiley   +1 more source

Organizational Characteristics of Hospitals Meeting STRIDE Program Adoption Benchmarks to Support Mobility for Hospitalized Persons

Inquiry: The Journal of Health Care Organization, Provision, and Financing
There are few validated contextual measures predicting adoption of evidence-based programs. Variation in context at clinical sites can hamper dissemination.
Leah L. Zullig PhD, MPH, Connor Drake PhD, Amy Webster BS, Matthew Tucker BA, Ashley Choate MPH, Karen M. Stechuchak MS, Cynthia J. Coffman PhD, Caitlin B. Kappler MSW, Cassie Meyer BS, Courtney H. Van Houtven PhD, Kelli D. Allen PhD, Jaime M. Hughes PhD, MPH, MSW, Nina Sperber PhD, Susan Nicole Hastings MD, MHS   +13 more
doaj   +1 more source

Progress in Pharmacogenomics Implementation in the United States: Barrier Erosion and Remaining Challenges

Clinical Pharmacology &Therapeutics, EarlyView.
Barriers to incorporating pharmacogenetics into routine clinical practice in the United States are well documented. Initial surveys by the Clinical Pharmacogenetics Implementation Consortium (CPIC) in 2009 and 2010 identified barriers across four key domains that have hindered the widespread adoption of clinical pharmacogenetic testing.
D. Max Smith, Michael P. Douglas, Christina L. Aquilante, Patricia A. Deverka, Beth Devine, Henry M. Dunnenberger, Philip E. Empey, Daniel L. Hertz, Andrew A. Monte, Ann M. Moyer, Jai N. Patel, Victoria M. Pratt, Loren Saulsberry, Stuart A. Scott, Deepak Voora, Erica L. Woodahl, Michelle Whirl‐Carrillo, Akinyemi Oni‐Orisan, on behalf of the Pharmacogenomics Global Research Network (PGRN) Publications Committee   +18 more
wiley   +1 more source

An Analysis of Current Healthcare Proposals: Obama and McCain [PDF]

, 2008
The healthcare system of the U.S. is broken. The next opportunity for overwhelming healthcare system reform will be when the next president takes office.
Terrell, Dan
core   +1 more source